Regeneron Prescription drugs REGN has outperformed the market over the previous 15 years by 10.66% on an annualized foundation producing a median annual return of twenty-two.46%. At present, Regeneron Prescription drugs has a market capitalization of $64.44 billion.
Shopping for $100 In REGN: If an investor had purchased $100 of REGN inventory 15 years in the past, it might be value $2,139.25 right this moment based mostly on a value of $596.85 for REGN on the time of writing.
Regeneron Prescription drugs’s Efficiency Over Final 15 Years
Lastly — what is the level of all this? The important thing perception to take from this text is to notice how a lot of a distinction compounded returns could make in your money development over a time frame.
This text was generated by Benzinga’s automated content material engine and reviewed by an editor.
Market Information and Information dropped at you by Benzinga APIs
© 2025 Benzinga.com. Benzinga doesn’t present funding recommendation. All rights reserved.